About this trial
The maxillary nerve block is a regional anesthetic technique targeting the sensory distribution of the maxillary nerve and is particularly preferred to provide analgesia in midfacial and maxillary surgical procedures. It has been used to optimize perioperative and postoperative pain control, reduce intraoperative opioid requirements, and support hemodynamic stability in procedures including septorhinoplasty, nasal bone osteotomies, nasal valve surgery, and endoscopic sinus surgery. This study aimed to compare the effects of the timing of bilateral maxillary nerve block administration (post-intubation vs. pre-extubation) on intraoperative remifentanil consumption and postoperative analgesia in patients undergoing septorhinoplasty.
Eligibility criteria
Qualifiers
18 to 65 years old
American Society of Anesthesiologists (ASA) physical status I-II
Body mass index 18 to 30 kg/m2
Septorhinoplasty surgery
Disqualifiers
Patient refusing the procedure
Patients who have previously undergone nasal surgery
Chronic opioid or analgesic use
Patients with allergies to local anesthetics
Trial design
Treatments tested in this trial
- Preoperative Maxillary Block
- Postoperative Maxillary Block
Treatment groups
Sponsors and collaborators
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Lead sponsor
Ankara Etlik City Hospital
Sponsor institution